Date / Time | Nov. 18 (Thu), 08:30-10:00 | |
---|---|---|
Channel | Channel 4 | |
Chair(s) |
Chong-Il Sohn (Sungkyunkwan Univ., Korea) Hidekazu Suzuki (Tokai Univ. School of Medicine, Japan) Ching-Liang Lu (National Yang Ming Chiao Tung Univ., Taiwan) |
|
Discussant(s) | Myong Ki Baeg (Catholic Kwandong Univ., Korea) Mariko Hojo (Juntendo Univ. School of Medicine, Japan) Chien-Lin Chen (Hualien Tzu Chi Hosp., Taiwan) |
|
Speakers | 08:30-08:50 | Usefulness of high-resolution manometry for the management of oropharyngeal dysphagia Jung Ho Park (Kangbuk Samsung Hosp., Korea) |
08:50-09:10 | Functional dyspepsia -Diagnosis and treatment- Tadayuki Oshima (Hyogo College of Medicine, Japan) | |
09:10-09:30 | Esophageal mucosal histopathology may help differentiate achalasia from refractory gastroesophageal reflux disease Ping-Huei Tseng (National Taiwan Univ. Hosp., Taiwan) | |
09:30-09:40 | New parameter for quantifying bolus transit with high-resolution impedance manometry Eun Jeong Gong (Univ. of Ulsan, Korea) | |
09:40-09:50 | Assessment of esophagogastric junction in post-POEM reflux esophagitis Akinari Sawada (Osaka City Univ. Graduate School of Medicine, Japan) | |
09:50-10:00 | Comparison of manometric diagnosis by Chicago classification version 3.0 and 4.0 on esophageal high resolution manometry Yen-Po Wang (Taipei Veterans General Hosp., Taiwan) |
Date / Time | Nov. 18 (Thu), 10:15-11:45 | |
---|---|---|
Channel | Channel 4 | |
Chair(s) |
Joo Sung Kim (Seoul National Univ., Korea) Tadakazu Hisamatsu (Kyorin Univ. School of Medicine, Japan) Cheng-Tang Chiu (Linkou Chang Gung Memorial Hosp., Taiwan) |
|
Discussant(s) | Dong Il Park (Sungkyunkwan Univ., Korea) Masanao Nakamura (Nagoya Univ., Japan) Shu-Chen Wei (National Taiwan Univ. Hosp., Taiwan) |
|
Speakers | 10:15-10:35 | Early intervention in IBD: Why and how? Byong Duk Ye (Univ. of Ulsan, Korea) |
10:35-10:55 | Deep neural network for colonoscopy of ulcerative colitis Kento Takenaka (Tokyo Medical and Dental Univ. Hosp., Japan) | |
10:55-11:15 | Transmural healing: The dream or the ideal to be achieved Chen-Shuan Chung (Far Eastern Memorial Hosp., Taiwan) | |
11:15-11:25 | Big data research: Progress makes practice in IBD Jaeyoung Chun (Yonsei Univ., Korea) | |
11:25-11:35 | The role of endoscopy in inflammatory bowel disease Junji Umeno (Kyushu Univ. Hosp., Japan) | |
11:35-11:45 | Clostridium innocuum in inflammatory bowel disease Puo-hsien Le (Linkou Chang Gung Memorial Hosp., Taiwan) |
Date / Time | Nov. 18 (Thu), 12:25-13:55 | |
---|---|---|
Channel | Channel 4 | |
Chair(s) |
Myung-Hwan Kim (Univ. of Ulsan, Korea) Michiaki Unno (Tohoku Univ. Graduate School of Medicine, Surgery, Japan) Yu-Wen Tien (National Taiwan Univ. Hosp., Taiwan) |
|
Discussant(s) | Joon Seong Park (Yonsei Univ., Surgery, Korea) Masayuki Sho (Nara Medical Univ., Japan) Chiung-Yu Chen (National Cheng Kung Univ. Hosp., Taiwan) |
|
Speakers | 12:25-12:45 | Upfront surgery for resectable/borderline-resectable pancreatic cancer Yoo-Seok Yoon (Seoul National Univ., Surgery, Korea) |
12:45-13:05 | Neoadjuvant therapy for resectable/borderline-resectable pancreatic ductal adenocarcinoma Sohei Satoi (Kansai Medical Univ., Surgery, Japan) | |
13:05-13:25 | Should we perform neoadjuvant therapy in resectable pancreatic cancer? Yan-Shen Shan (National Cheng Kung Univ. Hosp., Taiwan) | |
13:25-13:35 | Neoadjuvant chemotherapy for resectable/borderline-resectable pancreatic cancer Jae Min Lee (Korea Univ., Korea) | |
13:35-13:45 | The strategies for resectable / borderline-resectable pancreatic cancer Shigenori Ei (Tokai Univ. School of Medicine, Japan) | |
13:45-13:55 | Reshaping resectable/borderline-resectable pancreatic cancer in the era of precision medicine Chien-hui Wu (National Taiwan Univ. Hosp., Taiwan) |
Date / Time | Nov. 18 (Thu), 14:10-15:40 | |
---|---|---|
Channel | Channel 4 | |
Chair(s) |
Young-Suk Lim (Univ. of Ulsan, Korea) Yasuhito Tanaka (Kumamoto Univ., Japan) Jia-Horng Kao (National Taiwan Univ. Hosp., Taiwan) |
|
Discussant(s) | Hyung Joon Yim (Korea Univ., Korea) Kiyoaki Ito (Aichi Medical Univ., Japan) Cheng-Yuan Peng (China Medical Univ. Hosp., Taiwan) |
|
Speakers | 14:10-14:30 | Optimize nucleot(s)ide analogues’ to prevent hepatocellular carcinoma in patients with chronic hepatitis B: A lesson from real-world evidence Jonggi Choi (Univ. of Ulsan, Korea) |
14:30-14:50 | Current status in hepatitis B management in Japan and future perspectives Tetsuya Hosaka (Toranomon Hosp., Japan) | |
14:50-15:10 | Towards Elimination of HBV Infection in Taiwan Chun-Jen Liu (National Taiwan Univ. Hosp., Taiwan) | |
15:10-15:20 | Identifying hepatocellular carcinoma risk of untreated chronic hepatitis B for timely antiviral intervention Gi-Ae Kim (Kyung Hee Univ., Korea) | |
15:20-15:30 | Role of host immune responses in achieving HBsAg loss Sachiyo Yoshio (The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Japan) | |
15:30-15:40 | Combined ALT/HBsAg kinetics for re-treatment decision in HBeAg-negative CHB patients with off-Nuc hepatitis flare Wen-Juei Jeng (Linkou Chang Gung Memorial Hosp., Taiwan) |